Nektar Therapeutics Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
E Is Low P/E The Key To Pick Top Performers?
Article By: Arie Goren
Saturday, May 12, 2018 9:04 AM EDT
I tried to find out if there was a correlation between the top 25 S&P 500 performers in the last 52 weeks ending on May 11, to their price-earnings ratio a year ago on May 11, 2017. One year doesn't tell the tale.
In this article: NRG, NKTR Also: AMZN, NFLX, TTWO
NewLink Genetics Plunges After Competitor IDO Drug Fails In Trial
Article By: The Fly
Friday, April 6, 2018 1:08 PM EDT
Shares of NewLink Genetics (NLNK), a clinical-stage company focused on cancer, plunged in pre-market trading after a competitor exploring the same areas of cancer treatment reported a clinical trial that did not succeed in achieving its goal.
In this article: MRK, NLNK, NKTR
Bristol-Myers To Pay Nektar $1.85B In Cash, Stock As Part Of Collaboration Pact
Article By: The Fly
Wednesday, February 14, 2018 9:35 AM EDT
Bristol-Myers Squibb and Nektar Therapeutics announced the companies have executed a global strategic development and commercialization collaboration for Nektar's lead immuno-oncology program, NKTR-214.
In this article: BMY, NKTR
Alkermes Rises After Nektar Said To Explore Sale
Article By: The Fly
Friday, February 2, 2018 4:12 PM EDT
Shares of Alkermes have been rising this afternoon after Bloomberg reported that another drugmaker exploring some of the same therapeutic areas, Nektar Therapeutics, is exploring its strategic options, including a potential sale.
In this article: ALKS, NKTR
5 Terrific Small Caps - Monday, Dec. 18
Article By: Jim Van Meerten
Monday, December 18, 2017 12:40 PM EDT
Today's watch-list includes: Lending Tree, Nektar Therapeutics, Solaredge Technologies, LGI Homes and Rogers.
In this article: ROG, TREE, NKTR, LGIH, SEDG


Latest Tweets for $NKTR

No tweets yet!


Biotech Deal Sparks Rally
Susan Miller 2/15/2018 2:03:08 AM

I've had my eye on $NKTR.

1 to 1 of 1 comments